These Cd38 knock-out mice exhibit accelerated Type 1 diabetes onset.
Dr. Edward Leiter, The Jackson Laboratory
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Null/Knockout) | Cd38 | CD38 antigen |
Congenic NOD/Lt mice homozygous for the Cd38tm1Lnd mutation (Commonly referred to as NOD.Cd38 short) are viable, fertile and exhibit accelerated Type 1 diabetes onset in females and males. This acceleration has been correlated with further impairment of an already subnormal immunoregulatory network. Regulatory T-cells from these mice are more sensitive to NAD-mediated apoptosis when compared to NOD/Lt controls. Similarly, NOD-characteristic reductions in NKT cell numbers are further exacerbated in homozygous NOD.Cd38tm1Lnd mutant mice. Although CD38 is reportedly required for normal pancreatic beta cell responses to glucose, this was not confirmed in congenic, doubly homozygous NOD.PkrdcscidCD38tm1Lnd mutant mice.
NOD.129P2(B6)-Cd38tm1Lnd/LtJ mice are valuable for understanding how systemic NAD metabolism can be used to alter immunoregulatory networks.
CD38 (ADP ribosyl cyclase/cADPR hydrolase) is a Nicotinamide Adenine Dinucleotide (NAD) utilizing ectoenzyme involved in calcium mobilization. It is ubiquitously expressed to varying degrees on both hematopoietic and non-hematopoietic tissues. NAD released from target cell lysis that is not utilized by CD38 can elicit T cell apoptosis through the activity of another NAD-utilizing and T cell-specific ectoenzyme, ADP ribosyltransferase.A construct containing a neomycin expression cassette replacing exon 2 and 3 of Cd38 was transfected into E14-1 (129P2/OlaHsd-derived) embryonic stem cells (ES cells). These ES cells were injected into C57BL/6 blastocysts. As reported by Cockayne et al, 1998, chimeric founders were initially mated to C57BL/6 and intercrossed to generate homozygotes (B6.129P2-Cd38tm1Lnd). B6.129P2-Cd38tm1Lnd/J (stock# 3727)homozygote mice were subsequently mated to NOD/Lt for 11 generations prior to making homozygous. Marker assisted analysis indicates all known Idd loci are NOD/Lt in origin. In 2005, the T1DR received NOD.129P2(B6)-Cd38tm1Lnd/LtJ at generation N11F5.
Allele Name | targeted mutation 1, Frances E Lund |
---|---|
Allele Type | Targeted (Null/Knockout) |
Allele Synonym(s) | CD38-; CD38null; Cd38tm1Lud |
Gene Symbol and Name | Cd38, CD38 antigen |
Gene Synonym(s) | |
Strain of Origin | 129P2/OlaHsd |
Chromosome | 5 |
Molecular Note | A neomycin selection cassette replaced a genomic fragment containing exons 2 and 3, which encode the putative active site of the encoded protein. Homozygous mice lacked transcripts derived from this allele (data not shown). Flow cytometry analysis on splenocytes derived from homozygous mice confirmed that no detectable protein was expressed on the cell surface. |
Mutations Made By | Debra Cockayne, Roche Bioscience |
The accelerated diabetes development in NOD.129P2(B6)-Cd38tm1Lnd/LtJ homozygous breeding stock is not significantly retarded by either CFA or alpha galactosylceramide prophylaxis.
When using the NOD.CD38null mouse strain in a publication, please cite the originating article(s) and include JAX stock #004311 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Homozygous for Cd38<tm1Lnd>, 1 pair minimum |
Frozen Mouse Embryo | NOD.129P2(B6)-Cd38<tm1Lnd>/LtJ Frozen Embryos | $2595.00 |
Frozen Mouse Embryo | NOD.129P2(B6)-Cd38<tm1Lnd>/LtJ Frozen Embryos | $2595.00 |
Frozen Mouse Embryo | NOD.129P2(B6)-Cd38<tm1Lnd>/LtJ Frozen Embryos | $3373.50 |
Frozen Mouse Embryo | NOD.129P2(B6)-Cd38<tm1Lnd>/LtJ Frozen Embryos | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.